Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study

Morten Lamberts; Jonas Bjerring Olesen; Martin Huth Ruwald; Carolina Malta Hansen; Deniz Karasoy; Søren Lund Kristensen; Lars Køber; Christian Torp-Pedersen; Gunnar Hilmar Gislason; Morten Lock Hansen

doi:10.1161/CIRCULATIONAHA.112.114967

Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study

Morten Lamberts, Jonas Bjerring Olesen, Martin Huth Ruwald, Carolina Malta Hansen, Deniz Karasoy, Søren Lund Kristensen, Lars Køber, Christian Torp-Pedersen, Gunnar Hilmar Gislason, Morten Lock Hansen

Research output: Contribution to journal › Journal article › Research › peer-review

383 Citations (Scopus)

Abstract

Uncertainty remains over optimal antithrombotic treatment of patients with atrial fibrillation presenting with myocardial infarction and/or undergoing percutaneous coronary intervention. We investigated the risk and time frame for bleeding following myocardial infarction/percutaneous coronary intervention in patients with atrial fibrillation according to antithrombotic treatment.

Original language	English
Journal	Circulation
Volume	126
Issue number	10
Pages (from-to)	1185-93
Number of pages	9
ISSN	0009-7322
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.112.114967
Publication status	Published - 2012

Access to Document

10.1161/CIRCULATIONAHA.112.114967

Cite this

Lamberts, M., Olesen, J. B., Ruwald, M. H., Hansen, C. M., Karasoy, D., Kristensen, S. L., Køber, L., Torp-Pedersen, C., Gislason, G. H., & Hansen, M. L. (2012). Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study. Circulation, 126(10), 1185-93. https://doi.org/10.1161/CIRCULATIONAHA.112.114967

Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention : a nationwide cohort study. / Lamberts, Morten; Olesen, Jonas Bjerring; Ruwald, Martin Huth; Hansen, Carolina Malta; Karasoy, Deniz; Kristensen, Søren Lund; Køber, Lars ; Torp-Pedersen, Christian ; Gislason, Gunnar Hilmar; Hansen, Morten Lock.

In: Circulation, Vol. 126, No. 10, 2012, p. 1185-93.

Research output: Contribution to journal › Journal article › Research › peer-review

Lamberts, M, Olesen, JB, Ruwald, MH, Hansen, CM, Karasoy, D, Kristensen, SL, Køber, L , Torp-Pedersen, C , Gislason, GH & Hansen, ML 2012, 'Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study', Circulation, vol. 126, no. 10, pp. 1185-93. https://doi.org/10.1161/CIRCULATIONAHA.112.114967

Lamberts, Morten ; Olesen, Jonas Bjerring ; Ruwald, Martin Huth ; Hansen, Carolina Malta ; Karasoy, Deniz ; Kristensen, Søren Lund ; Køber, Lars ; Torp-Pedersen, Christian ; Gislason, Gunnar Hilmar ; Hansen, Morten Lock. / Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention : a nationwide cohort study. In: Circulation. 2012 ; Vol. 126, No. 10. pp. 1185-93.

@article{1c8744e1296342c1872a9b16c609f6dd,

title = "Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study",

abstract = "Uncertainty remains over optimal antithrombotic treatment of patients with atrial fibrillation presenting with myocardial infarction and/or undergoing percutaneous coronary intervention. We investigated the risk and time frame for bleeding following myocardial infarction/percutaneous coronary intervention in patients with atrial fibrillation according to antithrombotic treatment.",

author = "Morten Lamberts and Olesen, {Jonas Bjerring} and Ruwald, {Martin Huth} and Hansen, {Carolina Malta} and Deniz Karasoy and Kristensen, {S{\o}ren Lund} and Lars K{\o}ber and Christian Torp-Pedersen and Gislason, {Gunnar Hilmar} and Hansen, {Morten Lock}",

year = "2012",

doi = "10.1161/CIRCULATIONAHA.112.114967",

language = "English",

volume = "126",

pages = "1185--93",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams & Wilkins",

number = "10",

}

TY - JOUR

T1 - Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention

T2 - a nationwide cohort study

AU - Lamberts, Morten

AU - Olesen, Jonas Bjerring

AU - Ruwald, Martin Huth

AU - Hansen, Carolina Malta

AU - Karasoy, Deniz

AU - Kristensen, Søren Lund

AU - Køber, Lars

AU - Torp-Pedersen, Christian

AU - Gislason, Gunnar Hilmar

AU - Hansen, Morten Lock

PY - 2012

Y1 - 2012

N2 - Uncertainty remains over optimal antithrombotic treatment of patients with atrial fibrillation presenting with myocardial infarction and/or undergoing percutaneous coronary intervention. We investigated the risk and time frame for bleeding following myocardial infarction/percutaneous coronary intervention in patients with atrial fibrillation according to antithrombotic treatment.

AB - Uncertainty remains over optimal antithrombotic treatment of patients with atrial fibrillation presenting with myocardial infarction and/or undergoing percutaneous coronary intervention. We investigated the risk and time frame for bleeding following myocardial infarction/percutaneous coronary intervention in patients with atrial fibrillation according to antithrombotic treatment.

U2 - 10.1161/CIRCULATIONAHA.112.114967

DO - 10.1161/CIRCULATIONAHA.112.114967

M3 - Journal article

C2 - 22869839

VL - 126

SP - 1185

EP - 1193

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 10

ER -